A case of carrelizumab-associated immune myocarditis

Asian J Surg. 2022 Jan;45(1):496-497. doi: 10.1016/j.asjsur.2021.08.067. Epub 2021 Oct 8.

Authors

Lan-Zhen Zhao¹, Guang Liu¹, Quan-Fu Li¹, Gang Chen¹, Gao-Wa Jin²

Affiliations

¹ Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China.
² Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China. Electronic address: jingaowa_18@aliyun.com.

PMID: 34629265
DOI: 10.1016/j.asjsur.2021.08.067

No abstract available

Keywords: Adverse reaction; Carrelizumab; Myocarditis; PD-1 inhibitor.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Myocarditis* / chemically induced
Myocarditis* / diagnosis
Nivolumab

Substances

Antibodies, Monoclonal, Humanized
Nivolumab
camrelizumab